| Preferences for e-mental health interventions in Germany: a discrete choice experiment EA Phillips, SF Himmler, J Schreyögg Value in Health 24 (3), 421-430, 2021 | 47 | 2021 |
| Willingness to pay for an early warning system for infectious diseases S Himmler, J van Exel, M Perry-Duxbury, W Brouwer The European Journal of Health Economics 21 (5), 763-773, 2020 | 33 | 2020 |
| Estimating the monetary value of health and capability well-being applying the well-being valuation approach S Himmler, J van Exel, W Brouwer The European Journal of Health Economics 21, 1235-1244, 2020 | 19 | 2020 |
| What works better for preference elicitation among older people? Cognitive burden of discrete choice experiment and case 2 best-worst scaling in an online setting S Himmler, V Soekhai, J van Exel, W Brouwer Journal of choice modelling 38, 100265, 2021 | 18 | 2021 |
| Estimating an anchored utility tariff for the well-being of older people measure (WOOP) for the Netherlands S Himmler, M Jonker, F van Krugten, M Hackert, J van Exel, W Brouwer Social Science & Medicine 301, 114901, 2022 | 11 | 2022 |
| Preferences of psychotherapists for blended care in Germany: a discrete choice experiment EA Phillips, S Himmler, J Schreyögg BMC psychiatry 22 (1), 112, 2022 | 11 | 2022 |
| A case study applying a novel approach to estimate the social impact of a medical innovation-the use of secukinumab for psoriatic arthritis in Germany S Himmler, M Mueller, B Sherif, D Ostwald Expert Review of Pharmacoeconomics & Outcomes Research 20 (4), 369-378, 2020 | 10 | 2020 |
| What works better for preference elicitation among older people S Himmler, V Soekhai, J van Exel, W Brouwer Cognitive burden of discrete choice experiment and case 2, 2021 | 9 | 2021 |
| The societal impact of obinutuzumab in the first-line treatment of patients with follicular lymphoma in Germany S Hofmann, S Himmler, D Ostwald, U Dünzinger, A Launonen, ... Journal of Comparative Effectiveness Research 9 (14), 1017-1026, 2020 | 9 | 2020 |
| Did the COVID-19 pandemic change the willingness to pay for an early warning system for infectious diseases in Europe? S Himmler, J van Exel, W Brouwer The European Journal of Health Economics 23 (1), 81-94, 2022 | 8 | 2022 |
| Happy with your capabilities? Valuing ICECAP-O and ICECAP-A states based on experienced utility using subjective well-being data S Himmler, J van Exel, W Brouwer Medical Decision Making 40 (4), 498-510, 2020 | 8 | 2020 |
| Cost-effectiveness analysis of using dermatologists versus pediatricians to treat mild to moderate acne SA Davis, S Himmler, SR Feldman Dermatology Online Journal 23 (5), 2017 | 6 | 2017 |
| Braving the waves: exploring capability well-being patterns in seven European countries during the COVID-19 pandemic S Himmler, J van Exel, W Brouwer, S Neumann-Böhme, I Sabat, ... The European Journal of Health Economics 25 (4), 563-578, 2024 | 5 | 2024 |
| Do profit margins of pharmaceuticals influence reimbursement decisions? A discrete choice experiment among Dutch healthcare decision makers JJ Enzing, S Himmler, S Knies, WBF Brouwer Value in Health 25 (2), 222-229, 2022 | 5 | 2022 |
| The societal impact of a biologic treatment of ankylosing spondylitis: a case study based on secukinumab S Himmler, JC Branner, DA Ostwald Journal of Comparative Effectiveness Research 10 (2), 143-155, 2021 | 5 | 2021 |
| Netzwerkmedizin: Impulse für Deutschland aus den USA A Schmid, S Himmler Stiftung Münch, 2015 | 5 | 2015 |
| The value of health—Empirical issues when estimating the monetary value of a quality‐adjusted life year based on well‐being data S Himmler, J Stöckel, J van Exel, WBF Brouwer Health Economics 30 (8), 1849-1870, 2021 | 4 | 2021 |
| Long-term health benefits of stroke prevention with apixaban versus vitamin K antagonist warfarin in patients with non-valvular atrial fibrillation in Germany: a population … S Himmler, M Müller, D Ostwald, A Seddik, E Basic, E Hradetzky Expert Review of Pharmacoeconomics & Outcomes Research 19 (2), 223-230, 2019 | 4 | 2019 |
| Incidence trend of type 2 diabetes from 2012 to 2021 in Germany: an analysis of health claims data of 11 million statutorily insured people CT Lehner, M Eberl, E Donnachie, LF Tanaka, G Schauberger, ... Diabetologia 67 (6), 1040-1050, 2024 | 2 | 2024 |
| Gesundheitsökonomische Potenziale einer ganzheitlichen Nachsorge von Schlaganfallpatienten A Reichert, J Fröhlich, S Himmler, C Krauth, VE Amelung Gesundheitsökonomie & Qualitätsmanagement 22 (06), 297-305, 2017 | 2 | 2017 |
